A. Santoro, T. Tursz, H. Mouridsen, et al. Doxorubicin versus CYVADIC versus doxorubicin plus ifosfamide in first-line treat- ment of advanced soft tissue sarcomas: A randomized study of the European organization for research and treatment of cancer soft tissue and bone sarcoma group. Journal of Clinical Oncol- ogy, 1995, 13(7): 1531-1533.